10/6/2008 - Two drugs don't boost lung cancer survival: Roche

Roche Holding AG and Genentech Inc said on Monday a study into the perquisites of combining their Tarceva and Avastin drugs for lung cancer career did not show an raise in overall survival.

More: - Read the rest here